Increased HOX C13 expression in metastatic melanoma progression

Journal of Translational Medicine

Volumn 10, Issue 1, 2012, Pages

  Cantile, Monica ^a   Scognamiglio, Giosuè ^a   Anniciello, Annamaria ^a   Farina, Marisa ^a   Gentilcore, Giusy ^a   Santonastaso, Clemente ^a   Fulciniti, Franco ^a   Cillo, Clemente ^b   Franco, Renato ^a   Ascierto, Paolo A ^a   Botti, Gerardo ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

HOX genes; Melanoma cells; Metastases

Indexed keywords

HOX PROTEIN; MESSENGER RNA;

ADULT; ARTICLE; CANCER GROWTH; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GENE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; GENETIC MARKER; HISTOPATHOLOGY; HOX C13 GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MELANOMA CELL; MELANOMA SKIN CANCER; METASTASIS POTENTIAL; NEVUS; PRIMARY TUMOR; REAL TIME POLYMERASE CHAIN REACTION; TISSUE MICROARRAY;

CELL LINE, TUMOR; DISEASE PROGRESSION; FEMALE; GENES, HOMEOBOX; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; MIDDLE AGED; NEOPLASM METASTASIS; PARAFFIN EMBEDDING; REAL-TIME POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 84860812472     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-10-91     Document Type: Article

References (44)

1. Palmieri G, Capone M, Ascierto ML, Gentilcore G, Stroncek DF, Casula M, Sini MC, Palla M, Mozzillo N, Ascierto PA. Main roads to melanoma. J Transl Med. 2009, 14:86-102.
2. Stelnicki EJ, Kömüves LG, Kwong AO, Holmes D, Klein P, Rozenfeld S, et al. HOX homeobox genes exhibit spatial and temporal changes in expression during human skin development. J Invest Dermatol 1998, 110:110-115.
3. Yang M, Qing-feng LI, Zhang F. HOX genes in the skin. Chinese Medical Journal 2010, 123:2607-2612.
4. Song HF, Chai JK, Chen ML, Lin ZH. Differential display of homeobox gene expressions in the normal, wounded human fetal and adult skins by DNA microarray. Chin J Plast Surg (Chin) 2005, 21:372-374.
5. Cillo C. HOX Genes in Human Cancers. Invasion and Metastasis 1994-95, 14:38-49.
6. Cillo C, Faiella A, Cantile M, Boncinelli E. Homeobox genes and cancer. Exp Cell Res 1999, 248:1-9. 10.1006/excr.1999.4451, 10094807.
7. Nunes FD, de Almeida FC, Tucci R, de Sousa SC. Homeobox genes: a molecular link between development and cancer. Pesqui Odontol Bras 2003, 17:94-98. 10.1590/S1517-74912003000100018, 12908068.
8. Grier DG, Thompson A, Kwasniewska A, McGonigle GJ, Halliday HL, Lappin TR. The pathophysiology of HOX genes and their role in cancer. J Pathol 2005, 205:154-171. 10.1002/path.1710, 15643670.
9. Argiropoulos B, Humphries RK. Hox genes in hematopoiesis and leukemogenesis. Oncogene 2007, 26:6766-6776. 10.1038/sj.onc.1210760, 17934484.
10. Shah N, Sukumar S. The Hox genes and their roles in oncogenesis. Nat Rev Cancer 2010, 10:361-371. 10.1038/nrc2826, 20357775.
11. Ma XJ, Wang Z, Ryan PD, Isakoff SJ, Barmettler A, Fuller A. A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen. Cancer Cell 2004, 5:607-616. 10.1016/j.ccr.2004.05.015, 15193263.
12. Goetz MP, Suman VJ, Couch FJ, Ames MM, Rae JM, Erlander MG, Ma XJ, Sgroi DC, Reynolds CA, Lingle WL, Weinshilboum RM, Flockhart DA, Desta Z, Perez EA, Ingle JN. Cytochrome P450 2D6 and homeobox 13/interleukin-17B receptor: combining inherited and tumor gene markers for prediction of tamoxifen resistance. Clin Cancer Res 2008, 14:5864-5868. 10.1158/1078-0432.CCR-08-0619, 2596658, 18794098.
13. Rodriguez BA, Cheng AS, Yan PS, Potter D, Agosto-Perez FJ, Shapiro CL, Huang TH. Epigenetic repression of the estrogen-regulated Homeobox B13 gene in breast cancer. Carcinogenesis 2008, 29:1459-1465. 10.1093/carcin/bgn115, 2899848, 18499701.
14. Miao J, Wang Z, Provencher H, Muir B, Dahiya S, Carney E, Leong CO, Sgroi DC, Orsulic S. HOXB13 promotes ovarian cancer progression. Proc Natl Acad Sci U S A 2007, 104:17093-17098. 10.1073/pnas.0707938104, 2040435, 17942676.
15. Komuves LG, Ma XK, Stelnicki E, Rozenfeld S, Oda Y, Largman C. HOXB13 homeodomain protein is cytoplasmic throughout fetal skin development. Dev Dyn 2003, 227:192-202. 10.1002/dvdy.10290, 12761847.
16. Cantile M, Franco R, Tschan A, Baumhoer D, Zlobec I, Schiavo G, Forte I, Bihl M, Liguori G, Botti G, Tornillo L, Karamitopoulou-Diamantis E, Terracciano L, Cillo C. HOX D13 expression across 79 tumor tissue types. Int J Cancer 2009, 125:1532-1541. 10.1002/ijc.24438, 19488988.
17. Cillo C, Schiavo G, Cantile M, Bihl MP, Sorrentino P, Carafa V, D' Armiento M, Roncalli M, Sansano S, Vecchione R, Tornillo L, Mori L, De Libero G, Zucman-Rossi J, Terracciano L. The HOX gene network in hepatocellular carcinoma. Int J Cancer 2011, 129:2577-2587. 10.1002/ijc.25941, 21626505.
18. Simon R, Struckmann K, Schraml P, Wagner U, Forster T, Moch H, Fijan A, Bruderer J, Wilber K, Mihatsch MJ, Gasser T, Sauter G. Amplification pattern of12q13-q15 genes (MDM2, CDK4, GLI) in urinary bladder cancer. Oncogene 2002, 21:2476-2483. 10.1038/sj.onc.1205304, 11971182.
19. Wikman H, Nymark P, Väyrynen A, Jarmalaite S, Kallioniemi A, Salmenkivi K, Vainio-Siukola K, Husgafvel-Pursiainen K, Knuutila S, Wolf M, Anttila S. CDK4 is a probable target gene in a novel amplicon at 12q13.3-q14.1 in lung cancer. Genes Chromosomes Cancer 2005, 42:193-199. 10.1002/gcc.20122, 15543620.
20. Muthusamy V, Hobbs C, Nogueira C, Cordon-Cardo C, McKee PH, Chin L, Bosenberg MW. Amplification of CDK4 and MDM2 in malignant melanoma. Genes Chromosomes Cancer 2006, 45:447-454. 10.1002/gcc.20310, 16419059.
21. Willmore-Payne C, Holden J, Turner KC, Proia A, Layfield LJ. Translocations and amplifications of chromosome 12 in liposarcoma demonstrated by the LSI CHOP breakapart rearrangement probe. Arch Pathol Lab Med 2008, 132:952-957.
22. Barr FG, Duan F, Smith LM, Gustafson D, Pitts M, Hammond S, Gastier-Foster JM. Genomic and clinical analyses of 2p24 and 12q13-q14 amplification in alveolar rhabdomyosarcoma: a report from the Children's Oncology Group. Genes Chromosomes Cancer 2009, 48:661-672. 10.1002/gcc.20673, 2739400, 19422036.
23. Or YY, Chung GT, To KF, Chow C, Choy KW, Tong CY, Leung AW, Hui AB, Tsao SW, Ng HK, Yip TT, Busson P, Lo KW. Identification of a novel 12p13.3 amplicon in nasopharyngeal carcinoma. J Pathol 2010, 220:97-107. 10.1002/path.2609, 19718711.
24. Fischer U, Leidinger P, Keller A, Folarin A, Ketter R, Graf N, Lenhof HP, Meese E. Amplicons on chromosome 12q13-21 in glioblastoma recurrences. Int J Cancer 2010, 126:2594-2602.
25. Mejia-Guerrero S, Quejada M, Gokgoz N, Gill M, Parkes RK, Wunder JS, Andrulis IL. Characterization of the 12q15 MDM2 and 12q13-14 CDK4 amplicons and clinical correlations in osteosarcoma. Genes Chromosomes Cancer 2010, 49:518-525.
26. La Celle PT, Polakowska RR. Human homeobox HOXA 7 regulates keratinocyte transglutaminase type 1 and inhibit differentiation. J Biol Chem 2001, 276:32844-32853. 10.1074/jbc.M104598200, 11435435.
27. Jave-Suarez LF, Winter H, Langbein L, Rogers MA, Schweizer J. HOX C13 is involved in the regulation of Human Hair Keratin Gene Expression. The Journal of Biology Chemistry 2002, 277:3718-3716.
28. Awgulewitsch A. Hox in hair growth and development. Naturwissenschaften 2003, 90:193-211.
29. Pearson JC, Lemons D, McGinnis W. Modulating Hox gene functions during animal body patterning. Nat Rev Genet 2005, 6:893-904. 10.1038/nrg1726, 16341070.
30. Cantile M, Schiavo G, Terracciano L, Cillo C. Homeobox genes in normal and abnormal vasculogenesis. Nutr Metab Cardiovasc Dis 2008, 18:651-658. 10.1016/j.numecd.2008.08.001, 19013779.
31. Rinn JL, Wang JK, Liu H, Montgomery K, van de Rijn M, Chang HY. A systems biology approach to anatomic diversity of skin. J Invest Dermatol 2008, 128:776-782. 10.1038/sj.jid.5700986, 18337710.
32. Barber BA, Rastegar M. Epigenetic control of Hox genes during neurogenesis, development, and disease. Ann Anat 2010, 192:261-274. 10.1016/j.aanat.2010.07.009, 20739155.
33. Mallo M, Wellik DM, Deschamps J. Hox genes and regional patterning of the vertebrate body plan. Dev Biol 2010, 344:7-15. 10.1016/j.ydbio.2010.04.024, 2909379, 20435029.
34. Wellik DM. Hox genes and kidney development. Pediatr Nephrol 2011, 26:1559-1565. 10.1007/s00467-011-1902-1, 21553325.
35. Muragaki Y, Mundlos S, Upton J, Olsen BR. Altered growth and branching patterns in synpolydactyly caused by mutations in HOXD13. Science 1996, 272:548-551. 10.1126/science.272.5261.548, 8614804.
36. Mortlock DP, Innis J. Mutation of HOXA13 in hand-foot-genital syndrome. Nat Genet 1997, 15:179-180. 10.1038/ng0297-179, 9020844.
37. Miller GJ, Miller HL, van Bokhoven A, Lambert JR, Werahera PN, Schirripa O, Lucia MS, Nordeen SK. Aberrant HOXC expression accompanies the malignant phenotype in human prostate. Cancer Res 2003, 63:5879-5888.
38. Cillo C, Cantile M, Mortarini R, Barba P, Parmiani G, Anichini A. Differential patterns of HOX gene expression are associated with specific integrin and ICAM profiles in clonal populations isolated from a single human melanoma metastasis. Int J Cancer 1996, 66:692-697. 10.1002/(SICI)1097-0215(19960529)66:5<692::AID-IJC18>3.0.CO;2-6, 8647634.
39. Maeda K, Hamada J, Takahashi Y, Tada M, Yamamoto Y, Sugihara T, Moriuchi T. Altered expressions of HOX genes in human cutaneous malignant melanoma. Int J Cancer 2005, 114:436-441. 10.1002/ijc.20706, 15551325.
40. Riker AI, Enkemann SA, Fodstad O, Liu S, Ren S, Morris C, Xi Y, Howell P, Metge B, Samant RS, Shevde LA, Li W, Eschrich S, Daud A, Ju J, Matta J. The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis. BMC Med Genomics 2008, 1:13-28. 10.1186/1755-8794-1-13, 2408576, 18442402.
41. Seyhan AA. RNAi: a potential new class of therapeutic for human genetic disease. Hum Genet 2011, 30:583-605.
42. Sagerström CG. PbX marks the spot. Dev Cell 2004, 6:737-738. 10.1016/j.devcel.2004.05.015, 15177017.
43. Laurent A, Bihan R, Omilli F, Deschamps S, Pellerin I. PBX proteins: much more than Hox cofactors. Int J Dev Biol 2008, 52:9-20. 10.1387/ijdb.072304al, 18033668.
44. Morgan R, Pirard PM, Shears L, Sohal J, Pettengell R, Pandha HS. Antagonism of HOX/PBX dimer formation blocks the in vivo proliferation of melanoma. Cancer Res 2007, 67:5806-5813. 10.1158/0008-5472.CAN-06-4231, 17575148.